Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA-Incompatible Kidney Transplantation.

Orandi BJ, Zachary AA, Dagher NN, Bagnasco SM, Garonzik-Wang JM, Van Arendonk KJ, Gupta N, Lonze BE, Alachkar N, Kraus ES, Desai NM, Locke JE, Racusen LC, Segev DL, Montgomery RA.

Transplantation. 2014 Aug 13. [Epub ahead of print]

PMID:
25121475
[PubMed - as supplied by publisher]
2.

A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation.

Jackson AM, Kraus ES, Orandi BJ, Segev DL, Montgomery RA, Zachary AA.

Kidney Int. 2014 Jul 23. doi: 10.1038/ki.2014.261. [Epub ahead of print]

PMID:
25054778
[PubMed - as supplied by publisher]
3.

Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.

Gupta G, Abu Jawdeh BG, Racusen LC, Bhasin B, Arend LJ, Trollinger B, Kraus E, Rabb H, Zachary AA, Montgomery RA, Alachkar N.

Transplantation. 2014 Jun 27;97(12):1240-6. doi: 10.1097/01.TP.0000442503.85766.91.

PMID:
24937198
[PubMed - indexed for MEDLINE]
4.

Quantifying the risk of incompatible kidney transplantation: a multicenter study.

Orandi BJ, Garonzik-Wang JM, Massie AB, Zachary AA, Montgomery JR, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL.

Am J Transplant. 2014 Jul;14(7):1573-80. doi: 10.1111/ajt.12786. Epub 2014 Jun 9.

PMID:
24913913
[PubMed - in process]
5.

Differential Effect of Bortezomib on HLA Class I and Class II Antibody.

Philogene MC, Sikorski P, Montgomery RA, Leffell MS, Zachary AA.

Transplantation. 2014 May 28. [Epub ahead of print]

PMID:
24798311
[PubMed - as supplied by publisher]
6.

The role of donor-specific HLA alloantibodies in liver transplantation.

O'Leary JG, Demetris AJ, Friedman LS, Gebel HM, Halloran PF, Kirk AD, Knechtle SJ, McDiarmid SV, Shaked A, Terasaki PI, Tinckam KJ, Tomlanovich SJ, Wood KJ, Woodle ES, Zachary AA, Klintmalm GB.

Am J Transplant. 2014 Apr;14(4):779-87. doi: 10.1111/ajt.12667. Epub 2014 Mar 1.

PMID:
24580828
[PubMed - in process]
7.

Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients.

Bagnasco SM, Zachary AA, Racusen LC, Arend LJ, Carter-Monroe N, Alachkar N, Nazarian SM, Lonze BE, Montgomery RA, Kraus ES.

Transplantation. 2014 Feb 27;97(4):440-5. doi: 10.1097/01.TP.0000437177.40551.f4.

PMID:
24531821
[PubMed - indexed for MEDLINE]
8.

Histologic phenotype on 1-year posttransplantation biopsy and allograft survival in HLA-incompatible kidney transplants.

Sharif A, Kraus ES, Zachary AA, Lonze BE, Nazarian SM, Segev DL, Alachkar N, Arend LJ, Bagnasco SM, Racusen LC, Montgomery RA.

Transplantation. 2014 Mar 15;97(5):541-7. doi: 10.1097/01.TP.0000442513.27641.7e.

PMID:
24521779
[PubMed - indexed for MEDLINE]
9.

Desensitization for solid organ and hematopoietic stem cell transplantation.

Zachary AA, Leffell MS.

Immunol Rev. 2014 Mar;258(1):183-207. doi: 10.1111/imr.12150.

PMID:
24517434
[PubMed - in process]
10.

Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation.

Lonze BE, Zachary AA, Magro CM, Desai NM, Orandi BJ, Dagher NN, Singer AL, Carter-Monroe N, Nazarian SM, Segev DL, Streiff MB, Montgomery RA.

Am J Transplant. 2014 Feb;14(2):459-65. doi: 10.1111/ajt.12540. Epub 2014 Jan 8.

PMID:
24400968
[PubMed - in process]
11.

Red blood cell transfusions and the risk of allosensitization in patients awaiting primary kidney transplantation.

Leffell MS, Kim D, Vega RM, Zachary AA, Petersen J, Hart JM, Rossert J, Bradbury BD.

Transplantation. 2014 Mar 15;97(5):525-33. doi: 10.1097/01.tp.0000437435.19980.8f.

PMID:
24300013
[PubMed - indexed for MEDLINE]
12.

Time Course of Pathologic Changes in Kidney Allografts of Positive Crossmatch HLA-Incompatible Transplant Recipients.

Bagnasco SM, Zachary AA, Racusen LC, Arend LJ, Carter-Monroe N, Alachkar N, Nazarian SM, Lonze BE, Montgomery RA, Kraus ES.

Transplantation. 2013 Oct 29. [Epub ahead of print]

PMID:
24173106
[PubMed - as supplied by publisher]
13.

Transplanting the highly sensitized patient: trials and tribulations.

Iyer HS, Jackson AM, Zachary AA, Montgomery RA.

Curr Opin Nephrol Hypertens. 2013 Nov;22(6):681-8. doi: 10.1097/MNH.0b013e328365b3b9. Review.

PMID:
24076558
[PubMed - indexed for MEDLINE]
14.

Assessing immunologic risk factors in transplantation.

Philogene MC, Zachary AA.

Expert Rev Clin Immunol. 2013 Aug;9(8):773-9. doi: 10.1586/1744666X.2013.814413. Review.

PMID:
23971755
[PubMed - indexed for MEDLINE]
15.

Tetramer staining for the detection of HLA-specific B cells.

Lucas DP, Leffell MS, Zachary AA.

Methods Mol Biol. 2013;1034:313-8. doi: 10.1007/978-1-62703-493-7_17.

PMID:
23775745
[PubMed - indexed for MEDLINE]
16.

Transplantation of the sensitized patient: histocompatibility testing.

Montgomery RA, Leffell MS, Zachary AA.

Methods Mol Biol. 2013;1034:117-25. doi: 10.1007/978-1-62703-493-7_6.

PMID:
23775734
[PubMed - indexed for MEDLINE]
17.

Reply to "Defining the benefits of desensitization therapy".

Singer AL, Alachkar N, Montgomery RA, Zachary AA.

Transplantation. 2013 Mar 27;95(6):e33. doi: 10.1097/TP.0b013e3182845ffb. No abstract available.

PMID:
23507652
[PubMed - indexed for MEDLINE]
18.

Rituximab prevents an anamnestic response in patients with cryptic sensitization to HLA.

Zachary AA, Lucas DP, Montgomery RA, Leffell MS.

Transplantation. 2013 Mar 15;95(5):701-4. doi: 10.1097/TP.0b013e31827be3c1.

PMID:
23503502
[PubMed - indexed for MEDLINE]
19.

Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.

Gladstone DE, Zachary AA, Fuchs EJ, Luznik L, Kasamon YL, King KE, Brodsky RA, Jones RJ, Leffell MS.

Biol Blood Marrow Transplant. 2013 Apr;19(4):647-52. doi: 10.1016/j.bbmt.2013.01.016. Epub 2013 Jan 22.

PMID:
23353119
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.

Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G.

Transplantation. 2013 Jan 15;95(1):19-47. doi: 10.1097/TP.0b013e31827a19cc.

PMID:
23238534
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk